N1-[(7S)-6,7-Dihydro-6-oxo-5H-dibenz[b,d]azepin-7-yl]-2,2-dimethyl-N3-(2,2,3,3,3-pentafluoropropyl)propanediamide, 1mg

D-(+)-Pipecolic acid, 97.0%, 10g

1-(4'-Amino-biphenyl-3-yl)-ethanone hydrochloride, 98%, 1g

Hexadecyl 3,4,5-trihydroxybenzoate, 95%, 25g

5-Chloro-2-methyl-1H-indole-3-carbaldehyde, 95%, 250mg

(9H-Fluoren-9-yl)methyl ((S)-1-(((S)-1-((4-(((tert-butyldimethylsilyl)oxy)methyl)phenyl)amino)-1-oxo-5-ureidopentan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)carbamate, 98%, 100mg

Perfluorophenyl 2-(pyridin-3-yl)thiazole-4-carboxylate, 98%, 250mg

2-METHOXY-N-METHYLPYRIDIN-4-AMINE, 95.0%, 500mg

(6-Ethoxy-5-(trifluoromethyl)pyridin-3-yl)boronic acid, 98%, 250mg

Colonna capillare per GC ROTI®Cap-1701, 30 m, 0,32 mm, 0,35 µm, 1 Pezzo(i)

2-((2-Methoxyethyl)amino)propanoic acid hydrochloride, 250mg

tert-butyl 4-(3-methyl-2,5-dioxopiperazin-1-yl)piperidine-1-carboxylate, 250mg

(6-METHYLIMIDAZO[1,2-A]PYRIDIN-3-YL)METHANOL, 95.0%, 250mg